Related Experiment Video
Updated: Jul 4, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis
Sue J Sohn1, Gavin M Lewis, Astar Winoto
1Division of Immunology and Cancer Research Laboratory, Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3200, USA.
Abstract:
The mitogen-activated protein kinases (MAPKs) ERK1/2, p38, and JNK are thought to determine survival-versus-death fate in developing thymocytes. However, this view was challenged by studies using 'MEK1-ERK1/2-specific' pharmacological inhibitors, which block both positive and negative selection. Recently, these inhibitors were also shown to affect MEK5, an upstream activator of ERK5, another class of MAPK with homology to ERK1/2. To define the contribution of the MEK5-ERK5 pathway in T-cell development, we retrovirally expressed dominant-negative or constitutively activated form of MEK5 to inhibit or activate the MEK5-ERK5 pathway. We demonstrate that MEK5 regulates apoptosis of developing thymocytes but has no function in positive selection. ERK5 activity correlates with the levels of Nur77 family members but not that of Bim, two effector pathways of thymocyte apoptosis. These results illustrate the critical involvement of the MEK5-ERK5 pathway in thymocyte development distinct from that of ERK1/2 and highlight the importance of the MAPK network in mediating differential effects pertaining to T-cell differentiation and apoptosis.
Insights
The MEK5-ERK5 pathway regulates thymocyte apoptosis during T-cell development, distinct from ERK1/2 signaling. This finding clarifies the complex role of mitogen-activated protein kinases in T-cell differentiation and survival.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Mitogen-activated protein kinases (MAPKs) like ERK1/2, p38, and JNK are traditionally linked to thymocyte survival and death decisions.
- Previous studies using MEK1-ERK1/2 inhibitors yielded ambiguous results, potentially due to off-target effects on other MAPK pathways.
- The role of the MEK5-ERK5 pathway, a homolog of ERK1/2, in T-cell development remained unclear.
Purpose of the Study:
- To elucidate the specific contribution of the MEK5-ERK5 signaling pathway in T-cell development.
- To differentiate the functions of the MEK5-ERK5 pathway from the well-studied ERK1/2 pathway in thymocytes.
Main Methods:
- Retroviral expression of dominant-negative and constitutively activated MEK5 constructs in developing thymocytes.
- Analysis of thymocyte apoptosis and positive selection.
- Assessment of downstream effector pathways, including Nur77 family members and Bim.
Main Results:
- MEK5 activity was found to regulate thymocyte apoptosis.
- The MEK5-ERK5 pathway did not play a significant role in positive selection.
- ERK5 activity correlated with Nur77 family member levels, but not Bim levels, in thymocytes.
Conclusions:
- The MEK5-ERK5 pathway plays a critical, distinct role in regulating thymocyte apoptosis during T-cell development.
- These findings highlight the intricate MAPK network's involvement in mediating differential outcomes in T-cell differentiation and apoptosis.
- The study underscores the need to consider specific MAPK pathways when investigating T-cell fate determination.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis

